{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:49:04Z","timestamp":1773294544789,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.pnpbp.2005.11.032","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T15:37:09Z","timestamp":1146152229000},"page":"958-959","source":"Crossref","is-referenced-by-count":18,"title":["Prolongation of clozapine-induced leukopenia with olanzapine treatment"],"prefix":"10.1016","volume":"30","author":[{"given":"Aslihan","family":"Sayin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beh\u00e7et","family":"Cosar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2005.11.032_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(99)00957-5","article-title":"Olanzapine-induced neutropenia after clozapine-induced neutropenia","volume":"354","author":"Benedetti","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/15622970410029938","article-title":"Reversible neutropenia during treatment with olanzapine: three case reports","volume":"5","author":"Cordes","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2007-979204","article-title":"Genetic determinants of drug-induced agranulocytosis: potential risk for olanzapine?","volume":"32","author":"Dettling","year":"1999","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.jcp.0000117428.05703.16","article-title":"Olanzapine-induced neutropenia: mechanism and treatment","volume":"24","author":"Duggal","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1176\/appi.ajp.162.2.397","article-title":"Risperidone-induced morning pseudoneutropenia","volume":"162","author":"Esposito","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00004714-199712000-00014","article-title":"Prolongation of clozapine-induced granulocytopenia associated with olanzapine","volume":"17","author":"Flynn","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib8","series-title":"Adverse effects of psychotropic drugs","first-page":"378","author":"Kane","year":"1992"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00004714-200012000-00020","article-title":"Olanzapine prolongation of granulocytopenia after clozapine discontinuation","volume":"20","author":"Konakanchi","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1034\/j.1600-0447.2001.00429.x","article-title":"Agranulocytosis and granulocytopenia associated with quetiapine","volume":"104","author":"Ruhe","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.eurpsy.2003.03.009","article-title":"Risperidone induced leucopenia and neutropenia: a case report","volume":"19","author":"Sluys","year":"2004","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.032_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0278-5846(01)00258-5","article-title":"Olanzapine-induced agranulocytosis: a case report and review off literature","volume":"26","author":"Tolosa-Vilella","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605004021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605004021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T23:50:29Z","timestamp":1547682629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584605004021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0278584605004021"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2005.11.032","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}